Literature DB >> 11820227

Cancer nursing practice development: understanding breathlessness.

M Krishnasamy1, J Corner, M Bredin, H Plant, C Bailey.   

Abstract

This paper considers methodological and philosophical issues that arose during a multi-centre, randomized controlled trial of a new nursing intervention to manage breathlessness with patients with primary lung cancer. Despite including a diverse range of instruments to measure the effects of the intervention, the uniqueness of individuals' experiences of breathlessness were often hidden by a requirement to frame the study within a reductionist research approach. Evidence from the study suggests that breathlessness is only partly defined when understood and explored within a bio-medical framework, and that effective therapy can only be achieved once the nature and impact of breathlessness have been understood from the perspective of the individual experiencing it. We conclude that to work therapeutically we need to know how patients interpret their illness and its resultant problems and that this demands methodological creativity.

Entities:  

Mesh:

Year:  2001        PMID: 11820227     DOI: 10.1046/j.1365-2702.2001.00451.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  3 in total

1.  The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND.

Authors:  Marjolein H Gysels; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2011-10-17       Impact factor: 3.234

Review 2.  Non-invasive interventions for improving well-being and quality of life in patients with lung cancer.

Authors:  José-Ramón Rueda; Ivan Solà; Antonio Pascual; Mireia Subirana Casacuberta
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

3.  [Changes in quality of life and anxiety of lung cancer patients underwent chemotherapy].

Authors:  Shufang Li; Yan Wang; Shizhen Xin; Jiancun Cao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2012-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.